BLFS.NASDAQBiolife Solutions INC

Form 4: BioLife Solutions CHRO Sells Shares for Tax Obligations

Sentiment:

Insider Transaction Report

📋All filings for Biolife Solutions INC
🔒Login to Follow

BioLife Solutions' Chief Human Resources Officer, Sarah Aebersold, sold 188 shares of common stock at $27.36 per share to cover tax withholding obligations.

Summary

  • Sarah Aebersold, Chief Human Resources Officer of BIOLIFE SOLUTIONS INC (BLFS), reported a sale of common stock.
  • The transaction involved the disposition of 188 shares of common stock.
  • The shares were sold at a price of $27.36 per share.
  • The sale occurred on October 9, 2025.
  • This transaction was executed pursuant to a Rule 10b5-1(c) trading plan, which was adopted by the reporting person effective January 3, 2023.
  • The purpose of the sale was to satisfy tax withholding obligations in connection with the vesting of restricted stock.
  • Following this transaction, Sarah Aebersold beneficially owns 77,169 shares of common stock directly.

Sentiment

Score: 5

Explanation: The transaction is a routine, non-discretionary sale of shares to cover tax withholding obligations, executed under a pre-arranged 10b5-1 trading plan. It does not reflect a change in management's outlook or a discretionary decision to sell, thus having a neutral sentiment.

Future Outlook

N/A

Industry Context

N/A

Stakeholder Impact

  • Minimal impact on shareholders as this is a routine, non-discretionary transaction for tax purposes and represents a small fraction of the reporting person's total holdings.

Key Dates

DateDescription
01/03/2023Effective date of the Rule 10b5-1(c) trading plan adopted by Sarah Aebersold.
10/09/2025Date of the reported transaction (sale of common stock).
10/14/2025Date the Form 4 was signed by Sarah Aebersold.

Recommendation

hold

This Form 4 reports a routine, non-discretionary sale of a small number of shares by a corporate officer to satisfy tax withholding obligations related to restricted stock vesting. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan, indicating it was not based on new material non-public information. As such, it provides no new information to alter an existing investment thesis for BioLife Solutions and does not warrant a change in recommendation.

Keywords

BIOLIFE SOLUTIONS, BLFS, Form 4, Insider Transaction, Stock Sale, Tax Withholding, 10b5-1 Plan, Chief Human Resources Officer

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.